1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Clinical Trial Analysis
4.1. Ongoing Clinical Trials
4.2. Completed
Clinical Trials
4.3. Terminated
Clinical Trials
4.4. Breakdown
of Pipeline, By Development Phase
4.5. Breakdown
of Pipeline, By Status
4.6. Breakdown
of Pipeline, By Study Type
4.7. Breakdown
of Pipeline, By Region
4.8.
Clinical Trials Heat Map
5. Voice of Customer
6.
Nucleic Acid Sample
Preparation Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1. By Product
(Consumables, Systems and Accessories & Components)
6.2.2. By Technology
(Spin-Column Based Technology, Magnetic-Bead Based Technology and Others)
6.2.3. By Therapeutic
Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
6.2.4. By Application
(Genomics, Proteomics and Others)
6.2.5.
By End Users (Academic
and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical
and Diagnostic Laboratories and Other)
6.2.6.
By Company (2022)
6.2.7. By
Region
6.3. Product Market Map
7.
Asia-Pacific Nucleic
Acid Sample Preparation Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
Product
7.2.2.
Technology
7.2.3.
Therapeutic Area
7.2.4.
Application
7.2.5.
End Users
7.2.6.
By Country
7.3. Asia-Pacific: Country Analysis
7.3.1.
China Nucleic Acid
Sample Preparation Market Outlook.
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
Product
7.3.1.2.2.
Technology
7.3.1.2.3.
Therapeutic Area
7.3.1.2.4.
Application
7.3.1.2.5.
End Users
7.3.2.
India Nucleic Acid
Sample Preparation Market Outlook.
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
Product
7.3.2.2.2.
Technology
7.3.2.2.3.
Therapeutic Area
7.3.2.2.4.
Application
7.3.2.2.5.
End Users
7.3.3.
South Korea Nucleic
Acid Sample Preparation Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
Product
7.3.3.2.2.
Technology
7.3.3.2.3.
Therapeutic Area
7.3.3.2.4.
Application
7.3.3.2.5.
End Users
7.3.4.
Japan Nucleic Acid
Sample Preparation Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
Product
7.3.4.2.2.
Technology
7.3.4.2.3.
Therapeutic Area
7.3.4.2.4.
Application
7.3.4.2.5.
End Users
7.3.5.
Australia Nucleic
Acid Sample Preparation Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
Product
7.3.5.2.2.
Technology
7.3.5.2.3.
Therapeutic Area
7.3.5.2.4.
Application
7.3.5.2.5.
End Users
8.
Europe Nucleic Acid
Sample Preparation Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
Product
8.2.2.
Technology
8.2.3.
Therapeutic Area
8.2.4.
Application
8.2.5.
End Users
8.2.6.
By Country
8.3. Europe: Country Analysis
8.3.1.
France Nucleic Acid
Sample Preparation Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
Product
8.3.1.2.2.
Technology
8.3.1.2.3.
Therapeutic Area
8.3.1.2.4.
Application
8.3.1.2.5.
End Users
8.3.2.
Germany Nucleic Acid
Sample Preparation Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
Product
8.3.2.2.2.
Technology
8.3.2.2.3.
Therapeutic Area
8.3.2.2.4.
Application
8.3.2.2.5.
End Users
8.3.3.
United Kingdom Nucleic
Acid Sample Preparation Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
Product
8.3.3.2.2.
Technology
8.3.3.2.3.
Therapeutic Area
8.3.3.2.4.
Application
8.3.3.2.5.
End Users
8.3.4.
Italy Nucleic Acid
Sample Preparation Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
Product
8.3.4.2.2.
Technology
8.3.4.2.3.
Therapeutic Area
8.3.4.2.4.
Application
8.3.4.2.5.
End Users
8.3.5.
Spain Nucleic Acid
Sample Preparation Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
Product
8.3.5.2.2.
Technology
8.3.5.2.3.
Therapeutic Area
8.3.5.2.4.
Application
8.3.5.2.5.
End Users
9.
North America Humic-based
bio stimulants Market Outlook.
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
Product
9.2.2.
Technology
9.2.3.
Therapeutic Area
9.2.4.
Application
9.2.5.
End Users
9.2.6.
By Country
9.3. North America: Country Analysis
9.3.1.
United States Nucleic
Acid Sample Preparation Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
Product
9.3.1.2.2.
Technology
9.3.1.2.3.
Therapeutic Area
9.3.1.2.4.
Application
9.3.1.2.5.
End Users
9.3.2.
Mexico Nucleic Acid
Sample Preparation Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
Product
9.3.2.2.2.
Technology
9.3.2.2.3.
Therapeutic Area
9.3.2.2.4.
Application
9.3.2.2.5.
End Users
9.3.3.
Canada Nucleic Acid
Sample Preparation Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
Product
9.3.3.2.2.
Technology
9.3.3.2.3.
Therapeutic Area
9.3.3.2.4.
Application
9.3.3.2.5.
End Users
10.
South America Nucleic
Acid Sample Preparation Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
Product
10.2.2.
Technology
10.2.3.
Therapeutic Area
10.2.4.
Application
10.2.5.
End Users
10.2.6. By Country
10.3.
South America:
Country Analysis
10.3.1. Brazil Nucleic Acid Sample Preparation Market
Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
Product
10.3.1.2.2.
Technology
10.3.1.2.3.
Therapeutic Area
10.3.1.2.4.
Application
10.3.1.2.5.
End Users
10.3.2. Argentina Nucleic Acid Sample Preparation Market
Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
Product
10.3.2.2.2.
Technology
10.3.2.2.3.
Therapeutic Area
10.3.2.2.4.
Application
10.3.2.2.5.
End Users
10.3.3. Colombia Nucleic Acid Sample Preparation Market
Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
Product
10.3.3.2.2.
Technology
10.3.3.2.3.
Therapeutic Area
10.3.3.2.4.
Application
10.3.3.2.5.
End Users
11.
Middle East and
Africa Nucleic Acid Sample Preparation Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share &
Forecast
11.2.1.
Product
11.2.2.
Technology
11.2.3.
Therapeutic Area
11.2.4. Application
11.2.5. End Users
11.2.6. By Country
11.3.
MEA: Country
Analysis
11.3.1. South Africa Nucleic Acid Sample Preparation Market
Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
Product
11.3.1.2.2.
Technology
11.3.1.2.3.
Therapeutic Area
11.3.1.2.4.
Application
11.3.1.2.5.
End Users
11.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market
Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
Product
11.3.2.2.2.
Technology
11.3.2.2.3.
Therapeutic Area
11.3.2.2.4.
Application
11.3.2.2.5.
End Users
11.3.3. UAE Nucleic Acid Sample Preparation Market
Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
Product
11.3.3.2.2.
Technology
11.3.3.2.3.
Therapeutic Area
11.3.3.2.4.
Application
11.3.3.2.5.
End Users
11.3.4. Kuwait Nucleic Acid Sample Preparation Market
Outlook
11.3.4.1.
Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2.
Market Share & Forecast
11.3.4.2.1.
Product
11.3.4.2.2.
Technology
11.3.4.2.3.
Therapeutic Area
11.3.4.2.4.
Application
11.3.4.2.5.
End Users
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends & Developments
13.1.
Recent Developments
13.2.
Mergers &
Acquisitions
13.3.
Product Developments
14.
Competitive
Landscape
14.1.
Business Overview
14.2.
Company Snapshot
14.3.
Products &
Services
14.4.
Financials (In case
of listed companies)
14.5.
Recent Developments
14.6.
SWOT Analysis
14.6.1.
BGI Group (MGI Tech Co., Ltd.)
14.6.2.
F. Hoffmann-La Roche Ltd
14.6.3.
Danaher. (Beckman Coulter, Inc.)
14.6.4.
Eppendorf SE
14.6.5.
Bioneer Corporation
14.6.6.
Endress+Hauser Group Services AG (Analytik
Jena GmbH)
14.6.7.
Merck KGaA
14.6.8.
Norgen Biotek Corp
14.6.9.
Aurora Biomed Inc.
14.6.10.
Agilent Technologies, Inc
Strategic Recommendations